- In April 2023, Johnson & Johnson Vision announced the global expansion of its iDesign Refractive Studio, an advanced LASIK platform that offers personalized vision correction based on the unique optical fingerprint of each eye. The technology captures more than 1,200 eye measurements to create a custom treatment plan, improving outcomes and reducing post-operative side effects. This move reinforces the company’s commitment to enhancing precision and personalization in refractive surgery across key international markets
- In March 2023, Alcon Inc. launched an upgraded version of its WaveLight EX500 Excimer Laser System, introducing enhanced software capabilities that allow for more efficient treatment planning and faster surgical performance. Designed to reduce patient chair time and improve visual outcomes, the update reflects Alcon’s strategy to lead the market with advanced, surgeon-friendly refractive technologies that enhance procedural accuracy and safety
- In February 2023, Nidek Co., Ltd. received regulatory approval in several Asia-Pacific countries for its Navex Quest+ LASIK system, a comprehensive surgical suite that integrates corneal mapping, wavefront analysis, and femtosecond laser technologies. This approval is expected to boost Nidek’s presence in emerging LASIK markets by offering clinics an all-in-one solution for high-precision refractive correction
- In February 2023, Zeiss Medical Technology introduced its VISULAS Excimer Laser platform with real-time eye tracking and topography-guided capabilities in European markets. The system allows ophthalmologists to tailor LASIK procedures with higher accuracy, particularly for patients with complex corneal geometries. Zeiss’s innovation marks a strategic move to capture greater market share through premium technology and clinical precision
- In January 2023, LASIK MD, a leading refractive surgery provider based in Canada, announced a major partnership with regional surgical centers across North America to expand access to blade-free LASIK procedures. The collaboration aims to standardize high-quality care using femtosecond laser technology and increase affordability through flexible financing options, highlighting a growing emphasis on patient-centered care and market accessibility
